AVNS - Avanos Medical, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Revenue 652,300 611,600 566,200 509,000
Cost of Revenue 261,400 274,700 269,000 251,200
Gross Profit 390,900 336,900 297,200 257,800
Operating Expenses
Research Development 41,800 38,200 38,400 27,600
Selling General and Administrative 324,700 316,700 346,200 349,700
Non Recurring - - - -
Others 8,200 20,100 19,700 -800
Total Operating Expenses 636,100 649,700 673,300 627,700
Operating Income or Loss 16,200 -38,100 -107,100 -118,700
Income from Continuing Operations
Total Other Income/Expenses Net -34,300 -34,100 -32,100 -49,800
Earnings Before Interest and Taxes 16,200 -38,100 -107,100 -118,700
Interest Expense -26,400 -31,600 -32,700 -33,100
Income Before Tax -18,100 -72,200 -139,200 -168,500
Income Tax Expense -9,600 -40,100 -55,900 -67,300
Minority Interest - - - -
Net Income From Continuing Ops -8,500 -32,100 -83,300 -101,200
Non-recurring Events
Discontinued Operations 66,000 111,400 123,100 -325,100
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income
Net Income 57,500 79,300 39,800 -426,300
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares 57,500 79,300 39,800 -426,300